Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

Heinz Gisslinger; Christoph Klade; Pencho Georgiev; Dorota Krochmalczyk; Liana Gercheva-Kyuchukova; Miklos Egyed; Viktor Rossiev; Petr Dulicek; Arpad Illes; Halyna Pylypenko; Lylia Sivcheva; Jiri Mayer; Vera Yablokova; Kurt Krejcy; Hans C Hasselbalch; Robert Kralovics; Jean-Jacques Kiladjian

doi:10.1097/hs9.0000000000000485

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

Heinz Gisslinger
, Christoph Klade
, Pencho Georgiev
, Dorota Krochmalczyk
, Liana Gercheva-Kyuchukova
, Miklos Egyed
, Viktor Rossiev
, Petr Dulicek
, Arpad Illes
, Halyna Pylypenko
, Lylia Sivcheva
, Jiri Mayer
, Vera Yablokova
, Kurt Krejcy
, Hans C Hasselbalch
, Robert Kralovics
, Jean-Jacques Kiladjian

Haematology

Research output: Contribution to journal › Letter › Research › peer-review

Original language	English
Article number	e485
Journal	HemaSphere
Volume	4
Issue number	6
DOIs	https://doi.org/10.1097/hs9.0000000000000485
Publication status	Published - Dec 2020

Access to Document

10.1097/hs9.0000000000000485Licence: CC BY-NC-ND

Cite this

Gisslinger, H., Klade, C., Georgiev, P., Krochmalczyk, D., Gercheva-Kyuchukova, L., Egyed, M., Rossiev, V., Dulicek, P., Illes, A., Pylypenko, H., Sivcheva, L., Mayer, J., Yablokova, V., Krejcy, K., Hasselbalch, H. C., Kralovics, R., & Kiladjian, J.-J. (2020). Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups. HemaSphere, 4(6), Article e485. https://doi.org/10.1097/hs9.0000000000000485

@article{cc7335be08784c92857f3f45189da829,

title = "Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups",

author = "Heinz Gisslinger and Christoph Klade and Pencho Georgiev and Dorota Krochmalczyk and Liana Gercheva-Kyuchukova and Miklos Egyed and Viktor Rossiev and Petr Dulicek and Arpad Illes and Halyna Pylypenko and Lylia Sivcheva and Jiri Mayer and Vera Yablokova and Kurt Krejcy and Hasselbalch, \{Hans C\} and Robert Kralovics and Jean-Jacques Kiladjian",

year = "2020",

month = dec,

doi = "10.1097/hs9.0000000000000485",

language = "English",

volume = "4",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley \& Sons Inc.",

number = "6",

}

Gisslinger, H, Klade, C, Georgiev, P, Krochmalczyk, D, Gercheva-Kyuchukova, L, Egyed, M, Rossiev, V, Dulicek, P, Illes, A, Pylypenko, H, Sivcheva, L, Mayer, J, Yablokova, V, Krejcy, K, Hasselbalch, HC, Kralovics, R & Kiladjian, J-J 2020, 'Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups', HemaSphere, vol. 4, no. 6, e485. https://doi.org/10.1097/hs9.0000000000000485

TY - JOUR

T1 - Ropeginterferon Alfa-2b

T2 - Efficacy and Safety in Different Age Groups

AU - Gisslinger, Heinz

AU - Klade, Christoph

AU - Georgiev, Pencho

AU - Krochmalczyk, Dorota

AU - Gercheva-Kyuchukova, Liana

AU - Egyed, Miklos

AU - Rossiev, Viktor

AU - Dulicek, Petr

AU - Illes, Arpad

AU - Pylypenko, Halyna

AU - Sivcheva, Lylia

AU - Mayer, Jiri

AU - Yablokova, Vera

AU - Krejcy, Kurt

AU - Hasselbalch, Hans C

AU - Kralovics, Robert

AU - Kiladjian, Jean-Jacques

PY - 2020/12

Y1 - 2020/12

U2 - 10.1097/hs9.0000000000000485

DO - 10.1097/hs9.0000000000000485

M3 - Letter

C2 - 33134869

SN - 2572-9241

VL - 4

JO - HemaSphere

JF - HemaSphere

IS - 6

M1 - e485

ER -